Net Worth Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581K Sell
7,428
-361
-5% -$29.1K 0.15% 160
2026
Q1
$675K Sell
7,789
-155
-2% -$14.8K 0.14% 158
2025
Q4
$763K Buy
7,944
+453
+6% +$44K 0.15% 143
2025
Q3
$713K Sell
7,491
-168
-2% -$15.4K 0.21% 102
2025
Q2
$668K Buy
7,659
+162
+2% +$13.7K 0.15% 147
2025
Q1
$674K Buy
7,497
+31
+0.4% +$2.77K 0.21% 101
2024
Q4
$596K Buy
7,466
+18
+0.2% +$1.56K 0.18% 138
2024
Q3
$671K Buy
+7,448
New +$627K 0.2% 129

Other funds holding MDT

Net Worth Advisory Group's MDT Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Medtronic (MDT) stake by 4.6% in Q2 2026, selling an estimated $29.1K and leaving 7,428 shares worth $581K. The position accounts for 0.15% of the portfolio, ranked #160.

Net Worth Advisory Group first reported a position in MDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $763K in Q4 2025. 430 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Net Worth Advisory Group held 7,428 shares of Medtronic worth $581K as of Q2 2026.
  • Net Worth Advisory Group sold 361 Medtronic shares in Q2 2026, an estimated $29.1K.
  • Medtronic made up 0.15% of Net Worth Advisory Group's portfolio in Q2 2026, its #160 holding.
  • Net Worth Advisory Group first reported a position in Medtronic in Q3 2024 and has held it in 8 quarters since.
  • Net Worth Advisory Group's Medtronic position peaked at $763K in Q4 2025.
  • 430 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.